-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
bioAffinity Technologies, Inc. annual/quarterly Revenues history and growth rate from 2022 to 2023.
- bioAffinity Technologies, Inc. Revenues for the quarter ending September 30, 2023 was $300K.
- bioAffinity Technologies, Inc. annual Revenues for 2023 was $7.9M, a 14.5% increase from 2022.